Insider · CIK 0001247851

HUNT RONALD

Reports to the SEC for 16 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001247851

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-18	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+14.3K sh	$3.60	+$51.5K	14,305
2025-05-13	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+28.5K sh	—	—	28,500
2025-01-13	ITRMIterum Therapeutics plc · 6.500% Exchangeable Senior Subordinated Note due 2025J Other	Director	JOther	—	$2208000.00	—	—
2025-01-13	ITRMIterum Therapeutics plc · 6.500% Exchangeable Senior Subordinated Note due 2025J Other	Director	JOther	—	$792000.00	—	—
2025-01-02	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+73.6K sh	$0.70	+$51.5K	73,571
2024-08-06	ITRMIterum Therapeutics plc · Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+182K sh	—	—	182,453
2024-08-06	ITRMIterum Therapeutics plc · Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+182K sh	—	—	182,453
2024-08-06	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+182K sh	—	—	253,898
2024-08-06	ITRMIterum Therapeutics plc · Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+65.5K sh	—	—	65,481
2024-08-06	ITRMIterum Therapeutics plc · Subscription Rights (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−365K sh	—	—	0
2024-08-06	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+65.5K sh	—	—	91,122
2024-08-06	ITRMIterum Therapeutics plc · Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+65.5K sh	—	—	65,481
2024-08-06	ITRMIterum Therapeutics plc · Subscription Rights (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−131K sh	—	—	0
2024-05-15	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−10K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Common Stock Warrant (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−85.8K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−396K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−13.2K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−2,033 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1,016 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Common Stock Warrant (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−686K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Common Stock Warrant (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−299K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−3,214 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−2,300 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1.46M sh	—	—	0
2024-03-08	Harpoon Therapeutics, Inc.A Award	Director, 10% Owner	AAward	+424 sh	—	—	13,224
2024-01-02	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+29.1K sh	$1.77	+$51.5K	29,096
2024-01-01	Harpoon Therapeutics, Inc.A Award	Director, 10% Owner	AAward	+1,072 sh	—	—	12,801
2023-11-27	Harpoon Therapeutics, Inc.A Award	Director, 10% Owner	AAward	+5,000 sh	—	—	11,729
2023-10-25	Harpoon Therapeutics, Inc.Common Stock Warrant (Right to Buy)P Purchase	Director, 10% Owner	PPurchase	+686K sh	—	—	686,000
2023-10-25	Harpoon Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+172K sh	—	—	395,783
2023-10-25	Harpoon Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.37M sh	—	—	1,463,386
2023-10-25	Harpoon Therapeutics, Inc.Common Stock Warrant (Right to Buy)P Purchase	Director, 10% Owner	PPurchase	+85.8K sh	—	—	85,750
2023-10-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+5,479 sh	—	—	14,346
2023-10-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,479 sh	—	—	0
2023-10-01	Harpoon Therapeutics, Inc.A Award	Director, 10% Owner	AAward	+3,035 sh	—	—	6,729
2023-07-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+2,796 sh	—	—	8,867
2023-07-01	Harpoon Therapeutics, Inc.A Award	Director, 10% Owner	AAward	+18.7K sh	—	—	36,941
2023-07-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,796 sh	—	—	0
2023-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+23K sh	—	—	23,000
2023-05-17	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,490
2023-04-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,041 sh	—	—	0
2023-04-01	Harpoon Therapeutics, Inc.A Award	Director, 10% Owner	AAward	+18.3K sh	—	—	18,285
2023-04-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+2,041 sh	—	—	6,071
2023-03-23	Harpoon Therapeutics, Inc.Common Stock Warrant (Right to Buy)P Purchase	Director, 10% Owner	PPurchase	+2.99M sh	—	—	2,994,305
2023-03-23	Harpoon Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+10K sh	$1000.00	+$10M	10,000
2023-01-03	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,099
2023-01-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+1,197 sh	—	—	4,030
2023-01-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,197 sh	—	—	0
2022-12-23	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+5,479 sh	—	—	5,479

Recent filings

Accepted (ET)
Feb 204
HUNT RONALD0001739410-26-000015
SEC(opens sec.gov)
May 154
HUNT RONALD0001739410-25-000085
SEC(opens sec.gov)
Jan 234
HUNT RONALD0000950170-25-008443
SEC(opens sec.gov)
Jan 64
HUNT RONALD0001739410-25-000007
SEC(opens sec.gov)
Aug 124
HUNT RONALD0000950170-24-095094
SEC(opens sec.gov)
May 174
HUNT RONALD0001739410-24-000094
SEC(opens sec.gov)
Mar 114
HUNT RONALD0000950170-24-029446
SEC(opens sec.gov)

Companies

Address

C/O RALLYBIO CORPORATION 234 CHURCH STREET

NEW HAVEN, CT, 06510